Faissner, Simon http://orcid.org/0000-0002-3412-762X
Gold, Ralf
Article History
First Online: 29 March 2018
Change Date: 24 May 2018
Change Type: Correction
Change Details: An error was subsequently identified in the article, and the following correction should be noted.
Compliance with Ethical Standards
:
: The authors received no funding for the preparation of this article.
: Simon Faissner received travel grants from Biogen Idec and Genzyme. Ralf Gold received speaker’s and board honoraria from Baxter, Bayer Schering, Biogen Idec, CLB Behring, Genzyme, Merck Serono, Novartis, Stendhal, Talecris, and TEVA. His department received grant support from Bayer Schering, BiogenIdec, Genzyme, Merck Serono, Novartis, and TEVA.
Free to read: This content has been made available to all.